2016-09-22 13:54:47 UTC

AGA Perspectives Features Asymptomatic Pancreatic Cyst Debate

Sept. 22, 2016

The issue also provides quick takes on the growing role of GI in obesity treatment, big data in health care and the future of HCV therapy.

Check your inboxes. The new issue of AGA Perspectives is live online. The issue highlights a point/counterpoint discussion between James M. Scheiman, MD, AGAF, and Nuzhat A. Ahmad, MD, on the much debated topic of asymptomatic pancreatic cysts larger than 3 cm.

Dr. Scheiman argues for imagining surveillance, while Dr. Ahmad presents the case for EUS-FNA, and the debate touches on the AGA guideline on the same topic that was released in 2015.

The issue also provides quick takes on hot topics such as the growing role of GI in obesity treatment by Christopher C. Thompson, MD, MSC, FACG, FASGE, and an overview vedolizumab's role in IBD treatment and patient care by Edward V. Loftus Jr., MD, AGAF. Other articles touch on the role of big data in health care, the future of HCV therapy and more.

Read the full issue online at agaperspectives.org

 

More on Crohn's Disease

Attend the AGA Postgraduate Course for Practical, Take Home Information

Feb. 12, 2018

Join us on June 2-3 in Washington, D.C. This course is held in conjunction with Digestive Disease Week® (DDW) 2018.

Building an IBD Specialty Clinic from the Ground Up

Feb. 7, 2018

Gastro One in Tennessee developed an IBD clinic within their practice, which decreased emergency room visits by 70 percent.

4 New & Noteworthy IBD Drug Studies

Jan. 30, 2018

We recommend reviewing these four abstracts from the Crohn’s & Colitis Congress to keep informed on IBD treatment options.